India, EU firms fight 'epidemic of drug-resistance'

Singapore: India-based Orchid Pharma entered into a strategic partnership with Europe-based Allecra Therapeutics to deve...

April 19, 2013 | Friday | News
Wacker restructures sales network in Asia

Singapore: Munich-based Wacker Group is restructuring its sales network for biotech products in Asia to enhance efficien...

October 4, 2012 | Thursday | News
Genetic diagnostics usher in a new era in healthcare

Thanks to the Human Genome Project, scientists now have a set of tools that can be readily used to understand the comple...

December 18, 2012 | Tuesday | Analysis
Japanese acquisitions ahead for Lupin

Singapore: In a bid to expand its product portfolio, India's fourth largest domestic drug maker (in terms of revenue) is...

June 25, 2014 | Wednesday | News
ClinACE enters stem cell therapy development program

Singapore: ClinACE has collaborated with a stem cell banking and therapy company for conducting end-to-end clinical deve...

October 8, 2012 | Monday | News
Biocon in Science magazine Top 20 employers list

Bangalore: India-based premier biotechnology company, Biocon, has been ranked 19th in Science magazine's annual global '...

September 26, 2012 | Wednesday | News
OPPI holds conclave on healthcare in India

Bangalore: Improving access through innovation and research and development aimed at finding tomorrow's cures will conti...

July 31, 2012 | Tuesday | News
D A Prasanna is ACRO India's new Chairman

Singapore: On January 10 2014, members of Association of Contract Research Organizations (ACRO INDIA) met and Mr D A Pra...

January 16, 2014 | Thursday | News
Indian govt to revoke suspension of Pioglitazone

New Delhi: A month after the Indian government banned the popular anti-diabetes drug Pioglitazone, it is now planning to...

July 24, 2013 | Wednesday | News
India announces new biosimilar regulatory guidelines

Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been...

June 19, 2012 | Tuesday | Regulatory
Asia biologics manufacturers face the 'quality challenge'

Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy...

March 7, 2012 | Wednesday | News
Indian market expected to grow 12% during 2011-15

New Delhi: The global business intelligence firm, ResearchandMarket has filed their latest report with their projections...

August 1, 2013 | Thursday | News
FDA approves Italian facility of India's Strides Arcolab

Singapore: India's leading drug firm Strides Arcolab, with an agenda to foray into the semi-solid market in the US, has ...

September 19, 2013 | Thursday | News
Digital healthcare, the next big thing

A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies w...

August 7, 2013 | Wednesday | Opinion
Ranbaxy to sell vaccine business Biovel after facing loss

Bangalore: Ranbaxy is going to exit its Bangalore-based vaccine manufacturing company, Biovel, according to Business Sta...

November 26, 2013 | Tuesday | News
LifeCell gets $7 mn funding from Helion Venture

Bangalore: LifeCell International, India's largest and most accredited stem cell bank, secured an investment of $7 milli...

February 21, 2013 | Thursday | News
What makes a country competitive for a clinical research?

Any regulatory body's primary concern is to provide safe and efficacious medicine at an acceptable healthcare cost to ...

September 5, 2013 | Thursday | Opinion
Dr. Reddy's intends to buy Dutch firm

Hyderabad: Dr. Reddy's Laboratories, together with its subsidiaries, announced the intended public offer to acquire the...

October 23, 2012 | Tuesday | News